Dermatological toxicity of imatinib mesylate.

Simple item page
dc.contributor.authorPrasad, Nen_US
dc.contributor.authorDeshmukh, Cen_US
dc.contributor.authorBiswas, Gen_US
dc.contributor.authorBakshi, Aen_US
dc.contributor.authorSastry, P S R Ken_US
dc.contributor.authorParikh, P Men_US
dc.date.accessioned2005-04-01en_US
dc.date.accessioned2009-05-30T17:29:02Z
dc.date.available2005-04-01en_US
dc.date.available2009-05-30T17:29:02Z
dc.date.issued2005-04-01en_US
dc.description.affiliationDepartment of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai, India 400012.en_US
dc.identifier.citationPrasad N, Deshmukh C, Biswas G, Bakshi A, Sastry PS, Parikh PM. Dermatological toxicity of imatinib mesylate. Journal of the Association of Physicians of India. 2005 Apr; 53(): 298en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/84933
dc.language.isoengen_US
dc.source.urihttps://www.japi.orgen_US
dc.subject.meshAdulten_US
dc.subject.meshErythema --chemically induceden_US
dc.subject.meshHumansen_US
dc.subject.meshHyperpigmentation --chemically induceden_US
dc.subject.meshLeukemia, Myelogenous, Chronic, BCR-ABL Positive --drug therapyen_US
dc.subject.meshMaleen_US
dc.subject.meshPiperazines --adverse effectsen_US
dc.subject.meshProtein Kinase Inhibitors --adverse effectsen_US
dc.subject.meshPyrimidines --adverse effectsen_US
dc.titleDermatological toxicity of imatinib mesylate.en_US
dc.typeCase Reportsen_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Journal of the Association of Physicians of India